A Phase I Study of Lenalidomide and Ibrutinib in Combination with Rituximab - Regional Cancer Care Associates LLC

Clinical Trials

A Phase I Study of Lenalidomide and Ibrutinib in Combination with Rituximab

Type of Cancer
Lymphoma
Locations
Hackensack
Sponsor
Georgetown
Protocol Number
Georgetown 2013-1342 (NCI 9540)
Cancer Diagnosis
To Learn More Call
201-510-0910